Loading…
Back To Schedule
Monday, June 25 • 11:00am - 12:00pm
#107: The Metamorphosis of Clinical Trials: Evolving Roles of Stakeholders in Digital Trials

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-18-520-L04-P; CME 1.00; IACET 1.00; RN 1.00

This session will examine the promise of virtual trials to address challenges of traditional site-based models by examining the evolving roles of study stakeholders, patients, investigators, and study managers, and how they improve study performance

Learning Objectives

Describe the potential promise, benefits, and considerations of virtual clinical trials to address challenges to clinical trial conduct and participation; Define the evolution of stakeholder roles, existing and new, and the interplay between them, in virtual/direct to patient clinical trials; Apply insights to inform virtual trial design and planning.

Chair

Josh Rose, MBA

Speaker

Panelist
Angela Botto-van Bemden, PhD

Panelist
Jeff Kingsley, DO, MBA

Panelist
Christina Markus, JD

Panelist
Robert Goldman, PhD


Speakers
avatar for Angela Botto-van Bemden

Angela Botto-van Bemden

Director, OA Programs, Arthritis Foundation
TBD- MCT Stakeholder Perceptions project, CTTI
avatar for Robert Goldman

Robert Goldman

Head, Global Medical Affairs, Sunovian
avatar for Jeff Kingsley

Jeff Kingsley

Chief Executive Officer, IACT Health
Dr. Kingsley is founder and CEO of IACT Health, a research management organization, and twelve wholly owned and integrated clinical research offices. The companies conduct phase Ib through IV research in nearly every medical specialty; inpatient and outpatient; pharmaceutical, biotechnology... Read More →
avatar for Christina Markus

Christina Markus

Partner/Attorney, King & Spalding LLP
Chris Markus is a lawyer representing life sciences companies, researchers, and investors on compliance and enforcement under laws administered by FDA, DEA, and state agencies such as boards of pharmacy. She supports clients’ business operations and represents them in transactions... Read More →
avatar for Josh Rose

Josh Rose

Vice President, Global Head of Strategy, IQVIA
As Vice President and Global Head of Strategy for the R&D Solutions business unit at IQVIA, Josh Rose is responsible for building the overarching strategy for the clinical development business, establishing and governing strategic initiatives, and leading the identification of acquisition... Read More →

Monday June 25, 2018 11:00am - 12:00pm EDT
Room 257AB Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  02: ClinTrials -ClinOps, Forum